Wall Street predicts approval for another ALS drug
March 21, 2023 at 10:45 AM EDT
An FDA advisory committee is set to meet this week to discuss a drug developed by Biogen and Ionis to treat a rare form of Lou Gehrig's disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
Copyright © 1995-2016 Knight Sac Media. All rights reserved. | Stock quotes are delayed at least 15 minutes - See Terms of Use. |